Atopic Dermatitis (AD) Market Analysis 2015 – 2025: Industry Analysis, Regional Analysis and Future Prospects

Precisemarketreports.com adds new report “Atopic Dermatitis (AD) – Market Insights, Epidemiology and Market Forecast – 2025” which contains global key player’s survey information and forecast to 2022.

Overview of Atopic Dermatitis (AD) Market:

The “Atopic Dermatitis (AD) – Market Insights, Epidemiology and Market Forecast – 2025” research report covers the therapeutics market revenue, treatment practice/algorithm and forecasted market size of Atopic Dermatitis from 2017 to 2025 segmented by seven major markets. In addition, the forecasted epidemiology of Atopic Dermatitis till 2025 is also provided. This report also covers market drivers, market barriers and unmet medical need.

Get a Sample Copy of this Report @ https://www.precisemarketreports.com/report/sample/pmr-62764 .

United States contributes the major share of Atopic Dermatitis market as compared to EU5 countries and Japan. The therapeutic market of Atopic Dermatitis in 7MM is expected to grow with healthy CAGR value from 2015 – 2025. 

Market is driven by various approved drugs for Atopic Dermatitis such as Elidel (Novartis), Protopic (Fujisawa Healthcare) and Desonate (Bayer Healthcare). There has been a positive impact on the market with the approval of Eucrisa (Pfizer) and Dupilumab (Regeneron Pharmaceuticals / Sanofi) in 2016 and 2017 respectively.

Get a 20% Discount on Single User report spread across 144 pages @ https://www.precisemarketreports.com/report/discount/pmr-62764 .

Market Segments:

‘Atopic Dermatitis – Market Insights, Epidemiology and Market Forecast-2025’ report provides an overview of epidemiology and market trends of Atopic Dermatitis for the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

A complete analysis of the competitive landscape of the Global Atopic Dermatitis (AD) Market is provided in the report. This section includes company profiles of market key players. The profiles include contact information, gross, capacity, product details of each firm, price and cost. This report investigates new project feasibility with a purpose of enlightening new entrants about the possibilities in this market. In this report, thorough SWOT analysis & investment analysis is provided which forecasts imminent opportunities for the Atopic Dermatitis (AD) Market players.

To know more click here -> https://www.precisemarketreports.com/report/enquiry/pmr-62764 .

Key Coverage and Benefits:

  1. The report will help in developing business strategies by understanding the trends shaping and driving the Atopic Dermatitis market.
  2. The Report provides detailed historical and forecasted epidemiological data of Atopic Dermatitis in the 7MM i.e., United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2015-2025. 
  3. Organize sales and marketing efforts by identifying the best opportunities for Atopic Dermatitis in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan. 
  4. To understand the future market competition in the Atopic Dermatitis market and insightful review of the key market drivers and barriers.
  5. To understand the regulatory scenario in major markets.
  6. The Report covers the detailed historical and forecasted Atopic Dermatitis market covering the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Major Points in Table of Contents:

Global Atopic Dermatitis (AD) Market Report 2017

  1. Report Introduction 
    2. Atopic Dermatitis Market Overview at a Glance 
    3. Disease Background and Overview 
    4. Epidemiology and Patient Population 
    5. Treatment Practices 
    6. Treatment Algorithm 
    7. Treatment Failure 
    8. Treatment by class 
    9. Emerging Therapies 
    10. Nemolizumab: Galderma Pharma 
    11. Tralokinumab: LEO Pharma 
    12. Tradipitant: Vanda Pharmaceuticals 
    13. ZPL-389: Novartis 
    14. NST-141: Nippon Shinyaku 
    15. Serlopitant: Menlo Therapeutics 
    16. DS107: DS Biopharma 
    17. Asimadoline: Tioga Pharmaceuticals 
    18. GSK2894512: GlaxoSmithKline 
    19. Lebrikizumab: Roche 
    20. DMT210: Dermata Therapeutics 
    21. SNA-120: Sienna Biopharmaceutical 
    22. RVT-501: Roivant Sciences 
    23. OPA-15406: Otsuka Pharmaceutical 
    24. Current Unmet Need 
    25. Atopic Dermatitis: Market Analysis 
    26. Atopic Dermatitis: United States Market Outlook 
    27. Atopic Dermatitis: EU5 
    28. Market Outlook 
    29. Atopic Dermatitis: Japan Market Outlook 
    30. Market Drivers 
    31. Market Barriers 
    32. Expert Opinions 
    33. Appendix 

About us:

Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario.

Tier 1’s, SME’s startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.

Contact us:

Precise Market Reports

Office No. 48, Akshya Complex, Dhole Patil road,

Maharashtra, Pune – 411001

India.

sales@precisemarketreports.com

+1 (323) 744 6588

https://www.precisemarketreports.com

Designed by CyFocus.com
Powered by CyFocus.net
%d bloggers like this: